This article is available online at http://www.jlr.org the transcription of their own biosynthetic enzymes and of transporter proteins for bile acids. In humans, more than 99% of all bile acids are localized in tissues participating in enterohepatic circulation. However, some bile acids are also present in the systemic circulation at concentrations of 15 M after a meal or at concentrations of 5 M even between meals ( 4 ), whereas their concentrations are several ten-to several hundred-fold higher in the gallbladder, liver, and intestine ( 5 ). In addition, bile acids are known to exhibit immunosuppressive effects on cell-mediated immunity and macrophage functions ( 6-8 ). In view of these fi ndings, bile acids might be expected to function not only in the limited tissues involved in enterohepatic circulation, but also in the whole body as signaling molecules.
Bile acids are synthesized from cholesterol in mammalian liver and are excreted into the bile. Bile acids facilitate the formation of micelles, which promote the processing of dietary fat. Recently, bile acids have been shown to act as physiological ligands for farnesoid X receptor (FXR) (1) (2) (3) . Through the activation of FXR, bile acids regulate TGR5 agonist activity and affi nity were shown to be increased by neutral compounds obtained from the reduction of the side chain of bile acids. Therefore, we investigated the TGR5 agonist activity and affi nity of bile alcohols, which are neutral polyhydroxylated sterols with the same steroid nucleus as bile acids and are abundantly present in nature.
In the present study, we demonstrated that TGR5 activation and cAMP production in response to the bile alcohols varied with the position and number of the hydroxyl groups in the steroid side chain. In addition, we showed that the conformation of the steroidal nucleus of bile alcohols is also important for their activities as TGR5 agonists. Furthermore, we report that the selectivity of bile alcohols toward TGR5 increased as the number of hydroxyl groups in the side chain increased. Thus, we have provided new insights into the structure-activity relationships of bile alcohols as TGR5 agonists.
MATERIALS AND METHODS

Bile acids and bile alcohols
We obtained our general chemicals from Sigma-Aldrich (St. Louis, MO). Naturally occurring bile acids were purchased from Sigma-Aldrich or Steraloids (Newport, RI). 5 ␤ -Cholestane-
were synthesized as described previously ( 14 ) . 
Plasmids
The NIH Mammalian Gene Collection clone MGC: 40597 (also named pCMVSPORT6/hTGR5) was obtained from Invitrogen (Carlsbad, CA). cAMP response element (CRE)-driven luciferase reporter construct was obtained from SA Bioscience (Frederick, MD).
Transient transfections and reporter gene assays
The human embryonic kidney cell line 293T (HEK293T cells) was seeded at 50-60% confl uence in 96-well plates and was maintained in DMEM containing 10% FBS for 24 h prior to transfection. For transient transfections, the cells were rinsed with PBS and were transfected with 12.5 ng/well of CRE-driven luciferase reporter constructs and 18.75 ng/well of human TGR5 expression plasmids (pCMVSPORT6/hTGR5) using Attractene Transfection Reagent (Qiagen, Chatsworth, CA) in OPTI-MEM Ι reduced-serum medium (Invitrogen). Six hours after transfection, a volume of DMEM containing 20% fetal calf serum and equivalent to the amount of transfection media that was used was added to the cells. After a further 18 h of incubation, the cells were washed once with PBS and were treated for 5 h with different concentrations of each compound in fresh DMEM containing 0.5% delipidated serum. After treatment, the cells were lysed and luciferase activity was determined using the Dual-Luciferase® Reporter Assay System (Promega, Madison, WI) according to the manufacturer's instructions. The fi refl y luciferase activity was normalized to the Renilla luciferase activity for each well.
Huh-7 cells were maintained in DMEM containing 10% FBS and were seeded onto 24-well plates at 24 h prior to transfection. The cells were transfected with 188 ng of pFXRE-tk-Luc ( 35 ), 63 ng each of the pcDNA3.1 expression vectors for human FXR ␣ and RXR ␣ , and 313 ng of the pSV-␤ -galactosidase vector (Promega, Madison, WI) using Attractene Transfection Reagent (Qiagen, Chatsworth, CA). Three hours after transfection, the cells were exposed to each compound for 20 h in a medium containing 0.5% delipidated FBS. The cells were then lysed and the luciferase activity level was determined. The fi refl y luciferase activity was normalized to the ␤ -galactosidase activity for each well.
cAMP production analysis
HEK293T cells, in which the human TGR5 expression plasmid was transiently transfected using the above method, were washed with PBS and the medium was exchanged for cAMP assay medium [DMEM containing 0.1% (w/v) BSA and 0.5 mM 3-isobutyl-1-methylxanthine]. After incubation for 30 min at 37°C, the cells were treated with each compound in fresh cAMP assay medium for 30 min. After treatment, the cAMP amounts were determined using a cAMP screening kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. The Lowry protein assay was used to determine the total protein level ( 36 ) .
50% Effective concentrations and effi cacy determination
Assays were performed in triplicate for each condition. The EC 50 values of each compound were calculated using a probit Fig. 3 . Effect of length of steroid side chain of bile alcohol on TGR5 activation. TGR5 activation was evaluated using the luciferase reporter assay as described in the legend to Fig. 2 . The data represent the mean ± SD of three determinations. The compounds in the fi gure are indicated by the bracketed numbers. *: The parameter was not used for the calculation of EC 50 value.
by guest, on October 14, 2017 www.jlr.org Downloaded from activity at levels comparable to that of LCA ( Fig. 2 ) . Bile alcohols possessing a hydroxyl group at C-22, C-23, or C-24 each have two stereoisomers, and the activity of each isomer differed signifi cantly ( Fig. 2 ) . In particular, the 23(R)-isomer [6] and the 22(S)-isomer [9] exhibited minimal TGR5 agonist activity.
The effects of the length of the side chain in the bile alcohols on TGR5 agonist activity are shown in Fig. 3 . Among the bile alcohols with 23 to 26 carbon atoms and a CA-nucleus ( [10] -[13] ) and with 22 to 26 carbon atoms and a CDCA-nucleus ( [14] -[18] ), no signifi cant differences in the TGR5-activation ability and affi nity were observed ( Fig. 3 ) .
We also evaluated whether the A/B ring juncture conformation in the steroid nucleus of bile acids and bile alcohols affected TGR5 activation. As shown in Fig. 4 , 5 ␤ -bile acids containing a cis -oriented A/B ring had a higher TGR5 agonist activity and affi nity than their 5 ␣ -counterparts. Figure 5 shows the effects on TGR5 activation of a series of bile alcohols differing in their conformations at the C-5 position. In a group of bile alcohols with three hydroxyl groups at the 3 ␣ , 7 ␣ , and 12 ␣ positions in the steroid nucleus, the 5 ␤ -bile alcohols ( ( Fig. 5A ) . Similar results were also obtained in a group of bile alcohols with two hydroxyl groups at the 3 ␣ and 7 ␣ positions in the nucleus ( Fig. 5B ) . In addition, the abilities of these bile alcohols, especially those of the 5 ␤ -bile alcohols, to activate TGR5 increased as the number of hydroxyl groups in their side chain increased ( Fig. 5 ). analysis
Statistical analysis
The statistical analysis was performed using the Student t -test; a value of P < 0.05 was considered statistically signifi cant.
RESULTS
As depicted in Fig. 1 , 27 compounds of naturally occurring and chemically modifi ed bile alcohols were evaluated using a transient transfection assay for TGR5 activity. The HEK293T cells were cotransfected with CRE-driven luciferase reporter constructs and expression plasmids for human TGR5. LCA, which has the highest TGR5 agonist activity among the endogenous bile acids produced in humans, was used as a positive control. Because of their toxicity, the maximum concentration of bile alcohols examined in this study was 20 M. The effi cacy of each bile alcohol was expressed as the relative percentage of the TGR5 agonist activity of 10 M of LCA. The affi nity of bile alcohols to TGR5 was represented as the EC 50 value.
As shown in Fig. 2 , THC [1] , the side chain of which is the same as that of cholesterol, had a lower TGR5 activity (effi cacy = 36.1%) and affi nity (EC 50 = 3.39 M) than LCA (effi cacy = 100%, EC 50 = 0.18 M). Next, we evaluated whether a series of bile alcohols 4 . Effect of A/B ring juncture conformation of bile acids on TGR5 activation. The TGR5 activation ability in a series of both 5 ␣ -(allo-) and 5 ␤ -bile acids was evaluated using the luciferase reporter assay, as described in the legend to Fig. 2 . The data represent the mean ± SD of three determinations. *: The parameter was not used for the calculation of EC 50 value.
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To further confi rm the ability of these bile alcohols to modulate intracellular signaling, the intracellular cAMP concentration was measured as a predictive parameter of biological activity. The cAMP-production potencies of the bile alcohols that were tested were strongly correlated with the TGR5 agonist activities evaluated for this set of compounds using the luciferase assay ( Fig. 6 ) . In a series of bile alcohols with or without a hydroxyl group in their side chain ( [1][9] ), a remarkable difference in the cAMP-production levels was noted between each isomer of 5 ␤ -cholestane-3 ␣ ,7 ␣ ,12 ␣ ,23-tetrols ( In this study, we comprehensively elucidated the ability of naturally occurring bile alcohols, including intermediates in bile acid biosynthesis as well as chemically modifi ed bile alcohol derivatives, to act as TGR5 agonists.
First, we found that THC, which is an intermediate in the bile acid biosynthesis pathway, exhibited minimal TGR5 agonist activity in a cell-based luciferase assay, whereas 5 ␤ -cholestane-3 ␣ ,7 ␣ ,12 ␣ ,26-tetrol, a hydroxylation product at the terminal methyl group of THC, was a potential ligand for TGR5 ( Fig. 2 ) . These fi ndings suggested that the presence of a hydroxyl group (or oxygen atom) in the side chain is essential for TGR5 agonist activity. In addition, bile alcohols having a hydroxyl group at the C-22 to C-25 position in the side chain also activated TGR5, though the activity varied with the position and the confi guration of the hydroxyl group ( Fig. 2 ) . Signifi cant differences were also produced by the confi guration of the hydroxyl group at the C-22 and C-23 positions. Four isomers at C-22 and C-23 of 3 ␣ ,7 ␣ -dihydroxy-22,23-methylene-5 ␤ -cholan-24-oic acid and two isomers at C-23 of 3 ␣ ,7 ␣ (,12 ␣ )-di(tri)hydroxy-23-methyl-5 ␤ -cholan-24-oic acid have reportedly exhibited remarkable differences in TGR5 agonist activity ( 13, 47 ) . These previous results together with the present fi ndings strongly suggest that the stereochemistry of the substituent at the C-22 or C-23 position, irrespective of its hydrophilic (hydroxyl) or hydrophobic (alkyl) properties, substantially affects the ability of bile acids and bile alcohols to activate TGR5.
Second, the shortening of the side chain in bile alcohols did not signifi cantly affect the TGR5 agonist activity ( Fig.  3 ) . Even a C 22 -bile alcohol [14] exhibited some activity (EC 50 : 1.65 M, effi cacy: 83.3%). This result is consistent with the fact that C 21 -and C 22 -steroid hormones are able to activate TGR5 ( 13 ) . In contrast, progressive shortening of the side chain of bile acids reportedly attenuates TGR5 agonist activity and affi nity ( 13 ) . These contradictory fi ndings between the neutral compounds and bile acids remain to be elucidated.
Third, we examined the effect of the A/B ring junction in bile alcohols on the ability to activate TGR5. Because bile alcohols were also reported to activate FXR ( 37-39 ), we assessed the TGR5 selectivity of bile alcohols using the TGR5/FXR EC 50 ratio calculated from the EC 50 values for TGR5 and FXR. The EC 50 values computed using a probit analysis were both statistically signifi cant ( P < 0.01). A selective agonist for TGR5 was not found among the bile alcohols tested in the present study. However, an increasing number of hydroxyl groups in the side chain led to a decrease in the TGR5/FXR EC 50 ratio, indicating an increase in TGR5 selectivity ( Table 1 ). 27Among the bile alcohols that were tested in the present study, 5 ␤ -cholestane-3 ␣ ,7 ␣ ,26,27-tetrol [22] , which possess two hydroxyl groups in its side chain and has a CDCA-nucleus, exhibited the highest level of TGR5 selectivity.
DISCUSSION
TGR5 was recently identifi ed as a metabolic receptor that mediates the nongenomic potency of bile acids ( 9, 10 ) , whereas FXR is a nuclear receptor that modulates genomic effects on them ( 40 ) . TGR5 that has been activated by bile acids is thought to be involved in immunomodulation and hepatoprotection via the regulation of nitric oxide production and an increase in energy expenditure followed by the activation of thyroid hormone in brown adipose tissue, subsequently leading to the prevention of obesity ( 10, 11, 41 ) . Furthermore, TGR5 could play a critical in vivo role in the maintenance of glucose homeostasis ( 42 ) . Thus, TGR5 is an attractive target for the treatment of metabolic disorders.
Bile alcohols have long been known as the fi nal metabolites in cholesterol elimination and are major constituents of bile in evolutionarily primitive animals, such as fi shes and frogs ( 43, 44 ) . In addition, some bile alcohols are formed as intermediates in the bile acid biosynthesis pathway in mammals, including humans ( 44 ) . Bile alcohols are present as minor components in bile, feces and urine obtained from healthy controls (44) (45) (46) . We previously demonstrated that bile alcohols are potent FXR ligands as well as bile acids (37) (38) (39) . Therefore, investigating whether bile alcohols that are structurally and physiologically re- ( Fig. 5 ) . These results were supported by a cAMP production analysis, shown in Fig. 6 . These fi ndings suggest that the A/B ring juncture conformation of bile alcohols is an important factor for the expression of TGR5 agonist activity.
We recently reported that bile alcohols are potent ligands for FXR ( 39 ) . Therefore, the TGR5/FXR selectivity of bile alcohols was examined by calculating the ratio of the EC 50 for TGR5 to that for FXR as the agonist (Table 1) . The selectivity seemed to increase as the number of hydroxyl groups in the side chain increased. This result may be attributed to the tertiary protein structure of the ligand binding region in both receptors. Therefore, a site that interacts with the side chain of bile alcohols in the ligandbinding region of TGR5 might contain a larger number of charged amino acids residues compared with that of FXR. Additionally, the site of TGR5 that interacts with the side chain of bile alcohols is likely to be spatially broader than that of FXR. To elucidate these assumptions, a further study, such as crystal structure analysis of TGR5 protein with the ligand, would be required.
We previously demonstrated using 7 -methyl-LCA and 7 ␤ -methyl-CDCA that when a methyl group is inserted into the C-7 position of LCA and CDCA, respectively, the resulting compound has a higher affi nity and selectivity for TGR5 than its parent compound ( 13 ) . While this fi nding might indicate that the introduction of the hydrophobic methyl group into the steroid nucleus of bile acids elicits TGR5-selectivity, we could not examine such derivatives in the present study.
We focused on bile alcohols that exist in abundance in nature and discussed the structure-activity relationship between TGR5 and bile alcohols. Consequently, we have shown that some bile alcohols exert a TGR5 agonist activity equal to that of endogenous bile acids, although none of the agonist activities were more robust than that of 7 -LCA. Nevertheless, we are fi rmly convinced that the new insights into the structure-activity relationship obtained from the present study may lead to the development of a new agent for the treatment of metabolic syndrome.
